BTK-IN-31
BTK-IN-31 (Compound 2) is a selective, non-covalently reversible, and blood-brain barrier (BBB) permeable Btk inhibitor. BTK-IN-31 has research potential in immune disorders, cancer, cardiovascular disease, viral infections, inflammation, metabolic/endocrine dysfunction, and neurological disorders[1].
Product Specifications
CAS Number
2662512-02-7
UNSPSC
12352005
Target
Btk
Type
Reference compound
Related Pathways
Protein Tyrosine Kinase/RTK
Applications
Metabolism-protein/nucleotide metabolism
Field of Research
Cancer; Infection; Endocrinology; Metabolic Disease; Inflammation/Immunology; Neurological Disease; Cardiovascular Disease
Assay Protocol
https://www.medchemexpress.com/btk-in-31.html
Solubility
10 mM in DMSO
Smiles
NC1=NC=CN2C([C@H]3CC[C@@H](OC3)CO)=NC(C4=C(C=C(C=C4)OC5=CC=CC=C5)F)=C12
Molecular Formula
C24H23FN4O3
Molecular Weight
434.46
References & Citations
[1]Quan Zhou, et al. Btk inhibitors. Patent WO2021136219A1.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
